Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.9K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.9K
Clinical Trials01:16

Clinical Trials

11.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

1.3K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.3K
Hazard Ratio01:12

Hazard Ratio

740
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
740
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

580
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
580

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Fast Path from Innovation to Safe and Effective Medicines.

Clinical pharmacology and therapeutics·2025
Same author

Report of the European Medicines Agency Conference on RNA-Based Medicines.

Nucleic acid therapeutics·2024
Same journal

Prompt engineering of large language models for paper screening in medical meta-analyses and systematic reviews: A prospective comparative study - CORRIGENDUM.

Research synthesis methods·2026
Same journal

Evaluating the accuracy and speed of eight deduplication tools: A comparative study.

Research synthesis methods·2026
Same journal

A comparison of preprint search aggregators: comprehensive identification of preprints in the information retrieval stage of evidence syntheses.

Research synthesis methods·2026
Same journal

Meta-research on key metrics of preregistered scoping reviews.

Research synthesis methods·2026
Same journal

Facilitators and barriers to engaging patient partners in knowledge syntheses: A stage-based approach.

Research synthesis methods·2026
Same journal

Response to: Five methodological considerations for validating LLMs in risk of bias assessment.

Research synthesis methods·2026
See all related articles

Related Experiment Video

Updated: Apr 18, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K

Aggregating and analysing clinical trials data from multiple public registers using R package ctrdata.

Ralf Herold1

  • 1Regulatory Science and Innovation Taskforce, https://ror.org/01z0wsw92European Medicines Agency, Netherlands.

Research Synthesis Methods
|April 17, 2026
PubMed
Summary
This summary is machine-generated.

The ctrdata R package streamlines access to public clinical trial data. It enables reproducible analysis across multiple trial registers, enhancing drug development research and public health insights.

Keywords:
Clinical trialsR packagemeta-analysisstudy protocoltrial registerstrial results

More Related Videos

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.7K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.4K

Related Experiment Videos

Last Updated: Apr 18, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K
A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.7K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.4K

Area of Science:

  • Clinical trial data management
  • Public health research
  • Regulatory science

Background:

  • Publicly available clinical trial data is valuable but difficult to access and analyze across different registers.
  • Discrepancies in data models, definitions, and search parameters across registers hinder efficient research workflows.
  • A programmatic solution is needed to integrate and leverage data from multiple clinical trial registries.

Purpose of the Study:

  • To introduce the ctrdata R package, a tool designed to simplify the use of public clinical trial data.
  • To demonstrate how ctrdata facilitates user-friendly, reproducible workflows for data identification, download, and analysis.
  • To highlight the utility of ctrdata for researchers in public health, medicines, and regulatory science.

Main Methods:

  • Development of the open-source R package 'ctrdata'.
  • Integration with major clinical trial registers: EU Clinical Trials Information System (CTIS), EU Clinical Trials Register (EUCTR), ClinicalTrials.Gov (CTGOV), and ISRCTN.
  • Implementation of standardized workflows for accessing and analyzing trial data.

Main Results:

  • ctrdata provides a unified interface for accessing data from diverse clinical trial registers.
  • The package supports reproducible research by enabling systematic data retrieval and analysis.
  • Facilitates insights into drug development practices and informs future clinical research.

Conclusions:

  • ctrdata enhances the accessibility and utility of public clinical trial data for researchers.
  • The package supports collaborative research and the development of data-driven solutions for various stakeholders.
  • It addresses the need for a scientific-technical solution to overcome data integration challenges in clinical trial research.